Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts → Browse Latest Filings
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

2201
1
NCR VOYIX Corp NCR Voyix Reports 12% Revenue Decline, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | 16 days ago | 0 comments

2202
1
Jasper Therapeutics, Inc. Jasper Therapeutics Reports Third Quarter Financial Results, Net Loss of $18.6 Million

Via official filing (AI summary) | 16 days ago | 0 comments

2203
1
Rapport Therapeutics, Inc. Rapport Therapeutics Reports Financial Results, Advances Lead Product Candidate RAP-219

Via official filing (AI summary) | 16 days ago | 0 comments

2204
1
Applied Therapeutics Inc. Applied Therapeutics Reports Significant Cash Increase, Revenue Growth, and Net Loss in Latest Quarter

Via official filing (AI summary) | 16 days ago | 0 comments

2205
1
Vigil Neuroscience, Inc. Vigil Neuroscience Reports Q3 Financial Results, Net Loss of $19.3M

Via official filing (AI summary) | 16 days ago | 0 comments

2206
1
Akebia Therapeutics, Inc. Akebia Therapeutics Reports 11% Revenue Decline, Increased Net Losses in Q3 2024

Via official filing (AI summary) | 16 days ago | 0 comments

2207
1
Homology Medicines, Inc. Q32 Bio Reports Significant Financial Changes Following Merger, Anticipates Continued Losses

Via official filing (AI summary) | 16 days ago | 0 comments

2208
1
Cartesian Therapeutics, Inc. Cartesian Therapeutics Reports Decline in Revenue, Net Loss, and Increased Cash Reserves in Latest 10-Q Filing

Via official filing (AI summary) | 16 days ago | 0 comments

2209
1
CHIMERIX INC Chimerix Reports Mixed Financial Results, Focuses on Lead Product Development

Via official filing (AI summary) | 16 days ago | 0 comments

2210
1
Cullinan Oncology, Inc. Cullinan Therapeutics Reports Improved Financial Position, Net Loss in Latest Quarter

Via official filing (AI summary) | 16 days ago | 0 comments

2211
1
DIEBOLD NIXDORF, Inc Diebold Nixdorf Reports Revenue Growth, Net Loss in Latest Quarter

Via official filing (AI summary) | 16 days ago | 0 comments

2212
1
Repare Therapeutics Inc. Repare Therapeutics Reports Q3 Financial Results, Net Loss Improves Amid Strategic Reprioritization and Reduced Expenses

Via official filing (AI summary) | 16 days ago | 0 comments

2213
1
TREVENA INC Trevena Reports Significant Financial Changes, Net Loss Improvement, and Strategic Adjustments in 10-Q Filing

Via official filing (AI summary) | 16 days ago | 0 comments

2214
1
DUCOMMUN INC /DE/ Ducommun Incorporated Reports Strong Q3 and Nine-Month Financial Results with Revenue and Profitability Growth

Via official filing (AI summary) | 16 days ago | 0 comments

2215
1
BEYOND MEAT, INC. Beyond Meat Reports Mixed Q3 Results, Net Loss Narrows Amid Cost Reductions and Operational Challenges

Via official filing (AI summary) | 16 days ago | 0 comments

2216
1
Vivid Seats Inc. Vivid Seats Reports Mixed Q3 Results with Revenue Growth, Declining Profitability

Via official filing (AI summary) | 16 days ago | 0 comments

2217
1
Village Farms International, Inc. Village Farms International Reports 20% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | 16 days ago | 0 comments

2218
1
Orthofix Medical Inc. Orthofix Medical Reports 6.8% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | 16 days ago | 0 comments

2219
1
MidCap Financial Investment Corp MidCap Financial Investment Corporation Reports Strong Growth in Investment Income and Assets, Despite Rising Debt Costs

Via official filing (AI summary) | 16 days ago | 0 comments

2220
1
Zura Bio Ltd Zura Bio Reports Significant Financial Developments, Including 90% Increase in Operating Expenses and $188.2 Million in Cash and Cash Equivalents

Via official filing (AI summary) | 16 days ago | 0 comments

2221
1
Monte Rosa Therapeutics, Inc. Monte Rosa Therapeutics Reports Increased Collaboration Revenue and Reduced Losses, Enters Strategic Partnerships

Via official filing (AI summary) | 16 days ago | 0 comments

2222
1
First Watch Restaurant Group, Inc. First Watch Restaurant Group Reports 14.8% Revenue Growth, Net Income Decline in Q3 2024

Via official filing (AI summary) | 16 days ago | 0 comments

2223
1
MoonLake Immunotherapeutics MoonLake Immunotherapeutics Reports Significant Financial Developments, Net Loss Increases 210.8% in Latest Quarter

Via official filing (AI summary) | 16 days ago | 0 comments

2224
1
Chicago Atlantic Real Estate Finance, Inc. Chicago Atlantic Real Estate Finance Reports Mixed Q3 Results, Net Income Up 12%

Via official filing (AI summary) | 16 days ago | 0 comments

2225
1
IMMUNIC, INC. Immunic Reports Third Quarter Loss, Advances Clinical Programs and Leadership Team

Via official filing (AI summary) | 16 days ago | 0 comments